Enhanced expression of the central survival of motor neuron (SMN) protein during the pathogenesis of osteoarthritis

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 1, 2014, Pages 115-124

  Cucchiarini, Magali ^a   Madry, Henning ^a   Terwilliger, Ernest F ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Osteoarthritis progression; Pro inflammatory cytokines; SMN expression

Indexed keywords

INTERLEUKIN 1BETA; SMN1 PROTEIN, HUMAN; SURVIVAL MOTOR NEURON PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANIMAL; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL CULTURE; GENE EXPRESSION; GENETICS; HUMAN; KNEE OSTEOARTHRITIS; METABOLISM; OSTEOARTHRITIS PROGRESSION; PATHOLOGY; PHYSIOLOGY; PRO-INFLAMMATORY CYTOKINES; RABBIT; SEVERITY OF ILLNESS INDEX; SMN EXPRESSION;

OSTEOARTHRITIS PROGRESSION; PRO-INFLAMMATORY CYTOKINES; SMN EXPRESSION;

AGED; ANIMALS; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; GENE EXPRESSION; HUMANS; INTERLEUKIN-1BETA; OSTEOARTHRITIS, KNEE; RABBITS; SEVERITY OF ILLNESS INDEX; SURVIVAL OF MOTOR NEURON 1 PROTEIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84891372695     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12170     Document Type: Article

References (46)

1. Loeser RF, Goldring SR, Scanzello CR, et al. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012; 64: 1697-707.
2. Poole AR. An introduction to the pathophysiology of osteoarthritis. Front Biosci. 1999; 4: D662-70.
3. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol. 2007; 213: 626-34.
4. Lotz M, Loeser RF. Effects of aging on articular cartilage homeostasis. Bone. 2012; 51: 241-8.
5. Loughlin J. Genetics of osteoarthritis. Curr Opin Rheumatol. 2011; 23: 479-83.
6. Sandell LJ. Etiology of osteoarthritis: genetics and synovial joint development. Nat Rev Rheumatol. 2012; 8: 77-89.
7. Goldring MB, Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol. 2011; 23: 471-8.
8. Kapoor M, Martel-Pelletier J, Lajeunesse D, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011; 7: 33-42.
9. Goldring MB, Marcu KB. Epigenomic and microRNA-mediated regulation in cartilage development, homeostasis, and osteoarthritis. Trends Mol Med. 2012; 18: 109-18.
10. Sandell LJ, Aigner T. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res. 2001; 3: 107-13.
11. Goldring MB. The role of the chondrocyte in osteoarthritis. Arthritis Rheum. 2000; 43: 1916-26.
12. Aigner T, Soder S, Gebhard PM, et al. Mechanisms of disease: role of chondrocytes in the pathogenesis of osteoarthritis-structure, chaos and senescence. Nat Clin Pract Rheumatol. 2007; 3: 391-9.
13. Kraus VB, Burnett B, Coindreau J, et al. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage. 2011; 19: 515-42.
14. Patra D, Sandell LJ. Recent advances in biomarkers in osteoarthritis. Curr Opin Rheumatol. 2011; 23: 465-70.
15. Roach HI, Aigner T, Soder S, et al. Pathobiology of osteoarthritis: pathomechanisms and potential therapeutic targets. Curr Drug Targets. 2007; 8: 271-82.
16. van den Berg WB. Osteoarthritis year 2010 in review: pathomechanisms. Osteoarthritis Cartilage. 2011; 19: 338-41.
17. van der Kraan PM. Osteoarthritis year 2012 in review: biology. Osteoarthritis Cartilage. 2012; 20: 1447-50.
18. Wan L, Ottinger E, Cho S, et al. Inactivation of the SMN complex by oxidative stress. Mol Cell. 2008; 31: 244-54.
19. Zou T, Ilangovan R, Yu F, et al. SMN protects cells against mutant SOD1 toxicity by increasing chaperone activity. Biochem Biophys Res Commun. 2007; 364: 850-5.
20. Zou T, Yang X, Pan D, et al. SMN deficiency reduces cellular ability to form stress granules, sensitizing cells to stress. Cell Mol Neurobiol. 2011; 31: 541-50.
21. Schrank B, Gotz R, Gunnersen JM, et al. Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci USA. 1997; 94: 9920-5.
22. Fischer U, Liu Q, Dreyfuss G. The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell. 1997; 90: 1023-9.
23. Kerr DA, Nery JP, Traystman RJ, et al. Survival motor neuron protein modulates neuron-specific apoptosis. Proc Natl Acad Sci USA. 2000; 97: 13312-7.
24. Pellizzoni L, Charroux B, Rappsilber J, et al. A functional interaction between the survival motor neuron complex and RNA polymerase II. J Cell Biol. 2001; 152: 75-85.
25. Strasswimmer J, Lorson CL, Breiding DE, et al. Identification of survival motor neuron as a transcriptional activator-binding protein. Hum Mol Genet. 1999; 8: 1219-26.
26. Drissi H, Zuscik M, Rosier R, et al. Transcriptional regulation of chondrocyte maturation: potential involvement of transcription factors in OA pathogenesis. Mol Aspects Med. 2005; 26: 169-79.
27. Goldring MB. Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis. Ther Adv Musculoskelet Dis. 2012; 4: 269-85.
28. Cucchiarini M, Thurn T, Weimer A, et al. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9. Arthritis Rheum. 2007; 56: 158-67.
29. Yoshioka M, Coutts RD, Amiel D, et al. Characterization of a model of osteoarthritis in the rabbit knee. Osteoarthritis Cartilage. 1996; 4: 87-98.
30. Mankin HJ, Dorfman H, Lippiello L, et al. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am. 1971; 53: 523-37.
31. Kolb SJ, Gubitz AK, Olszewski RF Jr, et al. A novel cell immunoassay to measure survival of motor neurons protein in blood cells. BMC Neurol. 2006; 6: 6-10.
32. Cucchiarini M, Ekici M, Schetting S, et al. Metabolic activities and chondrogenic differentiation of human mesenchymal stem cells following recombinant adeno-associated virus-mediated gene transfer and overexpression of fibroblast growth factor 2. Tissue Eng Part A. 2011; 17: 1921-33.
33. Simard LR, Belanger MC, Morissette S, et al. Preclinical validation of a multiplex real-time assay to quantify SMN mRNA in patients with SMA. Neurology. 2007; 68: 451-6.
34. Coovert DD, Le TT, McAndrew PE, et al. The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet. 1997; 6: 1205-14.
35. Francis JW, Sandrock AW, Bhide PG, et al. Heterogeneity of subcellular localization and electrophoretic mobility of survival motor neuron (SMN) protein in mammalian neural cells and tissues. Proc Natl Acad Sci USA. 1998; 95: 6492-7.
36. La Bella V, Kallenbach S, Pettmann B. Post-translational modifications in the survival motor neuron protein. Biochem Biophys Res Commun. 2004; 324: 288-93.
37. Baron-Delage S, Abadie A, Echaniz-Laguna A, et al. Interferons and IRF-1 induce expression of the survival motor neuron (SMN) genes. Mol Med. 2000; 6: 957-68.
38. Lunke S, El-Osta A. The emerging role of epigenetic modifications and chromatin remodeling in spinal muscular atrophy. J Neurochem. 2009; 109: 1557-69.
39. Roach HI, Aigner T. DNA methylation in osteoarthritic chondrocytes: a new molecular target. Osteoarthritis Cartilage. 2007; 15: 128-37.
40. Iwahashi H, Eguchi Y, Yasuhara N, et al. Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature. 1997; 390: 413-7.
41. Young PJ, Day PM, Zhou J, et al. A direct interaction between the survival motor neuron protein and p53 and its relationship to spinal muscular atrophy. J Biol Chem. 2002; 277: 2852-9.
42. Lefebvre S, Burglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995; 80: 155-65.
43. Pearn J. Classification of spinal muscular atrophies. Lancet. 1980; 1: 919-22.
44. Melki J, Lefebvre S, Burglen L, et al. De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. Science. 1994; 264: 1474-7.
45. Thompson TG, DiDonato CJ, Simard LR, et al. A novel cDNA detects homozygous microdeletions in greater than 50% of type I spinal muscular atrophy patients. Nat Genet. 1995; 9: 56-62.
46. Lefebvre S, Burlet P, Liu Q, et al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet. 1997; 16: 265-9.